These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 33622113)

  • 21. Economic Burden of Palmoplantar Pustulosis in Sweden: A Population-based Register Study.
    Löfvendahl S; Norlin JM; Schmitt-Egenolf M
    Acta Derm Venereol; 2023 Jan; 103():adv00843. PubMed ID: 36621923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic burden of psoriasis with high comorbidity among privately insured patients in the United States.
    Pilon D; Teeple A; Zhdanava M; Ladouceur M; Ching Cheung H; Muser E; Lefebvre P
    J Med Econ; 2019 Feb; 22(2):196-203. PubMed ID: 30523738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
    Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M
    BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone.
    Ramaswamy K; Lechpammer S; Mardekian J; Huang A; Schultz NM; Sandin R; Wang L; Baser O; George DJ
    Adv Ther; 2020 May; 37(5):2083-2097. PubMed ID: 32112280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic Burden of Comorbidities in Patients with Psoriasis in the USA.
    Wu JJ; Suryavanshi M; Davidson D; Patel V; Jain A; Seigel L
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):207-219. PubMed ID: 36402940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis.
    Cai Q; Teeple A; Wu B; Muser E
    J Med Econ; 2019 Dec; 22(12):1290-1297. PubMed ID: 31262226
    [No Abstract]   [Full Text] [Related]  

  • 28. Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.
    Strand V; Shah R; Atzinger C; Zhou J; Clewell J; Ganguli A; Tundia N
    Curr Med Res Opin; 2020 Jan; 36(1):161-168. PubMed ID: 31433680
    [No Abstract]   [Full Text] [Related]  

  • 29. The genetic basis for most patients with pustular skin disease remains elusive.
    Mössner R; Wilsmann-Theis D; Oji V; Gkogkolou P; Löhr S; Schulz P; Körber A; Prinz JC; Renner R; Schäkel K; Vogelsang L; Peters KP; Philipp S; Reich K; Ständer H; Jacobi A; Weyergraf A; Kingo K; Kõks S; Gerdes S; Steinz K; Schill T; Griewank KG; Müller M; Frey S; Ebertsch L; Uebe S; Sticherling M; Sticht H; Hüffmeier U
    Br J Dermatol; 2018 Mar; 178(3):740-748. PubMed ID: 28887889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey.
    Eckert L; Gupta S; Amand C; Gadkari A; Mahajan P; Gelfand JM
    J Am Acad Dermatol; 2018 Jan; 78(1):54-61.e1. PubMed ID: 29017738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Necrosis Factor-alpha Induced Protein 3 Interacting Protein 1 Gene Polymorphisms and Pustular Psoriasis in Chinese Han Population.
    Han JW; Wang Y; Alateng C; Li HB; Bai YH; Lyu XX; Wu R
    Chin Med J (Engl); 2016 Jul; 129(13):1519-24. PubMed ID: 27364786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records.
    Zema CL; Valdecantos WC; Weiss J; Krebs B; Menter AM
    JAMA Dermatol; 2022 Oct; 158(10):1142-1148. PubMed ID: 35947363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic burden of generalized myasthenia gravis (MG) in the United States and the impact of common comorbidities and acute MG-events.
    Zhdanava M; Pesa J; Boonmak P; Cai Q; Pilon D; Choudhry Z; Souayah N
    Curr Med Res Opin; 2024 Jul; 40(7):1145-1153. PubMed ID: 38745448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
    Sugiura K
    J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
    Sanchez IM; Sorenson E; Levin E; Liao W
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings.
    Blauvelt A; Shi N; Murage MJ; Kern SA; Somani N; Burge R; Ridenour TL; Lew CR; Zimmerman NM; Zhu B
    J Med Econ; 2022; 25(1):741-749. PubMed ID: 35615978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA.
    Merola JF; Herrera V; Palmer JB
    Clin Rheumatol; 2018 Oct; 37(10):2751-2761. PubMed ID: 30051284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Real-World Costs, Healthcare Resource Utilization, and Comorbidity-Related Costs Between Ixekizumab and Secukinumab Among Biologic-Experienced Patients with Psoriasis Over 18 Months in the USA.
    Blauvelt A; Shi N; Somani N; Burge R; Zhu B; Ridenour T; Kern S; Lew C; Zimmerman N; Murage M
    Clin Drug Investig; 2023 Mar; 43(3):185-196. PubMed ID: 36840815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
    Benzian-Olsson N; Dand N; Chaloner C; Bata-Csorgo Z; Borroni R; Burden AD; Cooper HL; Cornelius V; Cro S; Dasandi T; Griffiths CEM; Kingo K; Koks S; Lachmann H; McAteer H; Meynell F; Mrowietz U; Parslew R; Patel P; Pink AE; Reynolds NJ; Tanew A; Torz K; Trattner H; Wahie S; Warren RB; Wright A; Barker JN; Navarini AA; Smith CH; Capon F;
    JAMA Dermatol; 2020 Nov; 156(11):1216-1222. PubMed ID: 32936291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.